Results: Should you buy Ramsay Health Care shares?

Is the Ramsay Health Care Limited (ASX:RHC) share price in the buy zone after today's half year result?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price will be on watch on Thursday following the release of the private hospital operator's half year results.

Here's a summary of how Ramsay performed in the first half compared to the prior corresponding period:

  • Revenue increase 14.9% to $5.1 billion (6.1% excluding Capio).
  • EBITDA up 9.8% to $728.6 million (7.2% excluding Capio).
  • Core net profit after tax up 1% to $290.8 million (1.8% excluding Capio).
  • Core earnings per share up 1.2% to 140.6 cents.
  • Interim dividend up 4.3% to 60 cents fully franked.
  • Outlook: Reiterated core EPS growth guidance of up to 2%.

What were the drivers of the result?

The Australia/Asia segment was the star performer during the period with Australia revenue growing 4.8% to $2.6 billion. EBITDA grew 5.7% to $484.6 million during the half. This was driven by volume growth and an ongoing focus on achieving operational efficiencies.

Over in the United Kingdom the company saw its revenue rise 1.6% to £209.6 million. Unfortunately, EBITDAR fell 9.2% to £44.8 million. Management advised that "while Q1 was challenging and impacted overall earnings for H1, we saw good recovery in NHS volume growth in Q2." It is optimistic this improvement will be maintained in the second half.

The Continental Europe segment delivered a 25.7% increase in revenue to €1.3 billion and a 19.1% lift in EBITDAR to €231.3 million. This was driven largely by the acquisition of the Capio business during the half. Excluding the acquisition, segment revenue would have been up 2.5% and EBITDAR would have lifted 5.3%.

Outlook.

Ramsay's managing director, Craig McNally, appeared cautiously optimistic on the company's outlook.

He noted that positive signs are emerging in the UK in respect to price and volume growth but warned that Brexit could pose some challenges in the short term.

In Australia Mr McNally admitted that there are short term challenges for the sector, but believes the long term outlook is positive.

Ramsay has reaffirmed its FY 2019 core EPS growth guidance of up to 2%, barring unforeseen circumstances.

Should you invest?

Based on Ramsay's guidance, I estimate that its shares are changing hands at 22x forward earnings. Given its current growth profile and outlook over the medium term, I think this makes its shares expensive.

In light of this, I would sooner buy healthcare shares such as CSL Limited (ASX: CSL) and ResMed Inc. (ASX: RMD) instead of Ramsay, unless its shares dropped back enough so they were trading at around 17x forward earnings.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »